Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

72293 1527666247HCLSReviewCanadaMay2018.pdf
Energy Boardroom

Chi-Med mulls independent China development of new drugs

19.02.2014 / Scripintelligence

The "standout performance" of its drug R&D division, led by Hutchison MediPharma, means that the group can now look at such independent activities for selected pipeline projects. "We will continue to negotiate more collaborations on our broader pipeline…

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: